Abstract
Background: In recent days, synthetic cannabinoid derivatives have become life threatening for young people. Here, we want to share a case of acute eosinophilic pneumonia triggered by inhalation of synthetic cannabinoid, new side effects of which are being detected day by day. Case Report: A 21-year-old male, who had no history of pulmonary diseases, was admitted to the clinic with shortness of breath. His oxygen saturation was measured as 85-86% in room air. Common irregular ground-glass opacities were observed in thorax radiology. His peripheral blood eosinophil count was 1100 cell/mm3 with a leukocyte differential of 12%. Sputum eosinophilia was also observed. The patient was diagnosed with acute eosinophilic pneumonia in terms of current clinical, radiological and laboratory findings. Rapid remission was achieved with corticosteroid therapy. Conclusion: This is the first reported case of acute eosinophilic pneumonia induced by synthetic cannabinoid inhalation.
Author supplied keywords
Cite
CITATION STYLE
Öcal, N., Doğan, D., Çiçek, A. F., Yücel, O., & Tozkoparan, E. (2016). Acute eosinophilic pneumonia with respiratory failure induced by synthetic cannabinoid inhalation. Balkan Medical Journal, 33(6), 688–690. https://doi.org/10.5152/balkanmedj.2016.151145
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.